What's New
31 October 2024
At the meeting of 1 October 2024 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| tooth decay (dental caries) | 74/2024 | 75/2024 |
| myelodysplastic neoplasm (syndrome) | 76/2024 | 77/2024 |
| non-melanoma malignant neoplasm of the skin | 78/2024 | 79/2024 |
| Merkel cell carcinoma | 80/2024 | 81/2024 |
| subcutaneous lipoma | 82/2024 | 83/2024 |
| trigeminal neuralgia or trigeminal neuropathy | 84/2024 | 85/2024 |
| Achilles tendinopathy | 86/2024 | 87/2024 |
| retrocalcaneal heel bursitis | 88/2024 | 89/2024 |
Notes:
- The investigation concerning “dental caries” has resulted in the determination of Statements of Principles concerning tooth decay (dental caries).
- The investigation concerning “myelodysplastic syndrome” has resulted in the determination of Statements of Principles concerning myelodysplastic neoplasm (syndrome).
- The investigation concerning “non-melanotic malignant neoplasm of the skin” has resulted in the determination of Statements of Principles concerning non-melanoma malignant neoplasm of the skin and Merkel cell carcinoma.
- The investigation concerning “lipoma” has resulted in the determination of Statements of Principles concerning subcutaneous lipoma.
- The investigations concerning “trigeminal neuralgia” and “trigeminal neuropathy” have resulted in the determination of Statements of Principles concerning trigeminal neuralgia or trigeminal neuropathy.
- The investigation concerning “Achilles tendinopathy and bursitis” has resulted in the determination of Statements of Principles concerning Achilles tendinopathy and retrocalcaneal heel bursitis.
Determined to revoke and not reissue Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| antiphospholipid syndrome | 69/2016 | 70/2016 |
The above SOPs and Revocations take effect from 19 November 2024.
Finalised Declaration for:
| Condition | Declaration | Reasons for Decision |
|---|---|---|
| antiphospholipid syndrome |
Completed Investigations
The above determinations, declarations and revocations conclude the previously advertised investigations into:
New Investigations
Decided to advertise the following investigations:
- relapsing polychondritis
- haemorrhoids
- fibromuscular dysplasia
- acquired cataract
- female sexual dysfunction
- animal envenomation
- schizophrenia
- malignant neoplasm of the brain
- smallpox
- bruxism
- analgesic nephropathy
- umbilical hernia
- spondylolisthesis and spondylolysis
- complex regional pain syndrome
- presbyopia
- hepatitis D
- hepatitis B
- ascariasis
- hookworm disease
- cirrhosis of the liver
The above declaration and investigation notices appear in the Government Notices Gazette of 30 October 2024.